SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-030473
Filing Date
2024-04-04
Accepted
2024-04-04 17:01:49
Documents
14
Period of Report
2024-04-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203322-8k_allarity.htm   iXBRL 8-K 37566
2 FIFTH CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ALLARITY THERA ea0203322ex3-1_allarity.htm EX-1.1 10077
  Complete submission text file 0001213900-24-030473.txt   234734

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE allr-20240401.xsd EX-101.SCH 3060
4 XBRL LABEL FILE allr-20240401_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE allr-20240401_pre.xml EX-101.PRE 22819
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0203322-8k_allarity_htm.xml XML 4006
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 24823827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)